ONYX Pharmaceuticals

Onyx field reps spared in Amgen's 300-job bloodletting
Fierce Pharma Marketing
Wed, 03/11/15 - 08:20 am
ONYX Pharmaceuticals
Amgen
M&A
layoffs
drug reps
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Fierce Pharma
Tue, 03/3/15 - 08:05 am
ONYX Pharmaceuticals
Amgen
Velcade
Kyprolis
Multiple Myeloma
Former Onyx CEO Returns to Biotech to Launch Boston Start Up
TheStreet.com
Mon, 12/15/14 - 10:45 am
Tony Coles
ONYX Pharmaceuticals
Yumanity Therapeutics
Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Yahoo/PR Newswire
Sat, 12/6/14 - 11:18 am
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
RTT News
Fri, 07/25/14 - 11:11 am
Bayer
ONYX Pharmaceuticals
Nexavar
breast cancer
Will Amgen’s Acquisition of Onyx Pay off Soon?
Motley Fool
Thu, 06/26/14 - 09:36 am
M&A
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results of NEXAVAR as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation was Not Met
Bloomberg
Tue, 03/11/14 - 08:22 am
Bayer
ONYX Pharmaceuticals
Nexavar
liver cancer
The Best Biotech CEO of 2013 is...
TheStreet.com
Tue, 12/17/13 - 08:49 am
biotech
Celgene
NPS Pharmaceuticals
Bristol-Myers Squibb
ONYX Pharmaceuticals
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment
Yahoo/PR NewsWire
Sat, 11/23/13 - 12:06 pm
Nexavar
Bayer
ONYX Pharmaceuticals
Amgen
thyroid cancer
refractory differential thyroid cancer
U.S. judge throws out SEC lawsuit over 'suspicious' Onyx trading
Yahoo/Reuters
Sat, 11/23/13 - 12:04 pm
ONYX Pharmaceuticals
SEC
lawsuits
Northwest Biotherapeutics Poses Onyx Like Potential
Seeking Alpha
Mon, 11/18/13 - 09:56 am
Northwest Biotherapeutics
Agenus
Celldex
ONYX Pharmaceuticals
ImmunoCellular Therapeutics
Karyopharm Therapeutics IPO Looks Promising
Seeking Alpha
Wed, 11/6/13 - 08:19 am
Karyopharm
IPOs
Pfizer
Aveo Oncology
ONYX Pharmaceuticals
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Yahoo
Tue, 10/1/13 - 08:50 am
Amgen
ONYX Pharmaceuticals
M&A
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Mon, 09/30/13 - 10:44 am
Amgen
Takeda
ONYX Pharmaceuticals
Kyprolis
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
With $29B in deals so far, 2013 shaping up as big M&A year
Fierce Pharma
Fri, 09/20/13 - 10:23 am
M&A
Valeant Pharmaceuticals
Bausch & Lomb
ONYX Pharmaceuticals
Amgen
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Amgen
Celgene
ONYX Pharmaceuticals
Keryx
Pluristem Therapeutics
NPS Pharmaceuticals
Amgen With Onyx Pharmaceuticals: Long-Term Analysis
Seeking Alpha
Wed, 09/4/13 - 01:15 pm
Amgen
ONYX Pharmaceuticals
M&A

Pages